About the Committee

The Committee on Assessment of Biohazards and Embryonic Stem Cell Research Oversight (CAB/ESCRO) was formed in January of 1975 to ensure the safe and responsible conduct of biological research at MIT. CAB/ESCRO reviews investigations involving potential health and safety problems associated with biological research. The composition and structure of the committee conforms to the requirements of the NIH Guidelines for Research Involving Recombinant DNA Molecules, and the National Academy of Sciences Guidance on Oversight of Embryonic Stem Cell Research (2005). The scope of the committee has changed over time to provide a more consistent and cohesive oversight process for a range of biological research and new technologies.

CAB/ESCRO is a Standing Institute Committee that reports to the Vice President for Research.